YUTIQ

Welcome to the Brand page for “YUTIQ”, which is offered here for In the statement, lines 4-9, is deleted, and class 5: drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, uveitis and retinal disease; pharmaceutical preparations for the treatment of ocular diseases and conditions, uveitis and retinal disease is inserted.;drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, uveitis and [ retinal vein occlusion, macular edema, macular disease, ] retinal disease; [ and glaucoma; ] pharmaceutical preparations for the treatment of ocular diseases and conditions, uveitis and [ retinal vein occlusion, macular edema, macular disease, age-related macular degeneration, ] retinal disease [ and glaucoma ];the non-latin characters in the mark transliterate to yutiq and this has no meaning in a foreign language.;the wording yutiq has no meaning in a foreign language.;sustained drug delivery systems for ocular drugs;.

Its status is currently believed to be active. Its class is unavailable. “YUTIQ” is believed to be currently owned by “EYEPOINT PHARMACEUTICALS US, INC.”